Revenue YoY
—
Operating Income YoY
-12.65%
Net Income YoY
-8.60%
Net Margin Δ
—
Net income bridge for SELLAS Life Sciences Group (SLS) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: -$2.33M-8.60%
Profit bridge breakdown for SELLAS Life Sciences Group (SLS) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | -$27.1M | — |
| Revenue | $0.00 | +0.0% |
| Cost of Revenue | $0.00 | -0.0% |
| Operating Expenses | -$3.53M | -151.7% |
| Other Income / Expense | $1.2M | +51.7% |
| Income Tax | $0.00 | -0.0% |
| Net Loss | -$29.5M | — |
- Prior Net Income-$27.1M
- Revenue$0.00
- Cost of Revenue$0.00
- Operating Expenses-$3.53M
- Other Income / Expense$1.2M
- Income Tax$0.00
- Net Loss-$29.5M
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
SELLAS Life Sciences Group (SLS) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
How this company returns cash to shareholders — buybacks, dividends, and stock splits.